These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 30355669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The Light Chain Defines the Duration of Action of Botulinum Toxin Serotype A Subtypes.
    Pellett S, Bradshaw M, Tepp WH, Pier CL, Whitemarsh RCM, Chen C, Barbieri JT, Johnson EA.
    mBio; 2018 Mar 27; 9(2):. PubMed ID: 29588398
    [Abstract] [Full Text] [Related]

  • 4. Purification and Characterization of Botulinum Neurotoxin FA from a Genetically Modified Clostridium botulinum Strain.
    Pellett S, Tepp WH, Bradshaw M, Kalb SR, Dykes JK, Lin G, Nawrocki EM, Pier CL, Barr JR, Maslanka SE, Johnson EA.
    mSphere; 2016 Mar 27; 1(1):. PubMed ID: 27303710
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vivo onset and duration of action varies for botulinum neurotoxin A subtypes 1-5.
    Pellett S, Tepp WH, Whitemarsh RC, Bradshaw M, Johnson EA.
    Toxicon; 2015 Dec 01; 107(Pt A):37-42. PubMed ID: 26130522
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Regulation of Botulinum Neurotoxin Synthesis and Toxin Complex Formation by Arginine and Glucose in Clostridium botulinum ATCC 3502.
    Fredrick CM, Lin G, Johnson EA.
    Appl Environ Microbiol; 2017 Jul 01; 83(13):. PubMed ID: 28455330
    [Abstract] [Full Text] [Related]

  • 14. Enhancing toxin-based vaccines against botulism.
    Przedpelski A, Tepp WH, Zuverink M, Johnson EA, Pellet S, Barbieri JT.
    Vaccine; 2018 Feb 01; 36(6):827-832. PubMed ID: 29307477
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activity of botulinum neurotoxin type D (strain 1873) in human neurons.
    Pellett S, Tepp WH, Scherf JM, Pier CL, Johnson EA.
    Toxicon; 2015 Jul 01; 101():63-9. PubMed ID: 25937339
    [Abstract] [Full Text] [Related]

  • 19. Comparison of extracellular and intracellular potency of botulinum neurotoxins.
    Cai F, Adrion CB, Keller JE.
    Infect Immun; 2006 Oct 01; 74(10):5617-24. PubMed ID: 16988237
    [Abstract] [Full Text] [Related]

  • 20. High resolution crystal structures of Clostridium botulinum neurotoxin A3 and A4 binding domains.
    Davies JR, Rees J, Liu SM, Acharya KR.
    J Struct Biol; 2018 May 01; 202(2):113-117. PubMed ID: 29288126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.